Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock
(NASDAQ:MNPR), WILMETTE, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar Therapeutics” or the “Company”), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced the closing of its previously announced best efforts public offering of shares of its common stock at a public […]